- Erythroblastic sarcoma with biallelic TP53 mutations and novel NUP214:: ABL1—new finding in erythroblastic sarcoma/acute erythroid leukemia
Rebecca Manzo et al. · Journal of Hematopathology · 2026
- Technical Validation of Insulin Immunoassay for Cross-Reactivity of Veterinary Insulins
Kristina M. Sevcik et al. · Graduate Medical Education Research Journal · 2026
- Loss of CD44 on Immunohistochemistry Shows Increased Likelihood of Early Recurrence in Non- Invasive Low-Grade Papillary Urothelial Carcinoma With a Minor (< 5%) High-Grade Component
Holly Mitzel et al. · Graduate Medical Education Research Journal · 2026
- Beyond Pituitary Neuroendocrine Tumors: Spectrum of 1101 Sellar/Suprasellar Region Masses in a Tertiary Referral Center in 36 Years
Lili Guo et al. · Graduate Medical Education Research Journal · 2026
- Liberal Renal Sinus Sampling After Introduction of Subspecialized Genitourinary Practice Leads to Upstaging and Optimal Management of Renal Cell Carcinoma
Rory Li et al. · Graduate Medical Education Research Journal · 2026
- Characterization of Chronic Intestinal Pseudo-Obstruction With Abnormal CD117 Staining: A Distinct Clinical Phenotype?
Kate McFarland et al. · Graduate Medical Education Research Journal · 2026
- 1147 CD24 Expression in Bone Marrow CD10-positive Mature Granulocytes Correlates with JAK2 Mutation Status and Patient’s Overall Survival in Primary Myelofibrosis
Ahmed Ahmed et al. · Laboratory Investigation · 2026
- 687 Characterization of Chronic Intestinal Pseudo-obstruction with Abnormal CD117 Staining: A Distinct Clinical Phenotype?
Kate McFarland et al. · Laboratory Investigation · 2026
- 1459 Pituitary Neuroendocrine Tumors: An Institutional Review of Recurrent/Metastatic Cases
Thomas J Auen et al. · Laboratory Investigation · 2026
- 1726 Liberal Renal Sinus Sampling After Introduction of Subspecialized Genitourinary Practice in a Large Academic Center Leads to Upstaging and Optimal Management of Renal Cell Carcinoma in a Significant Number of Cases
Rory Li et al. · Laboratory Investigation · 2026